PMC5469985_01
Esophageal tumor seen during EGD.
CRIGM2017-9343896.001.jpg
PMC5469985_01_CRIGM2017-9343896.001.jpg
fig1
Due to her complaints and findings of iron deficiency, esophagogastroduodenoscopy (EGD) was done and showed a mass at the distal esophagus causing a tight stricture (Figure 1).
H&E stain of the esophageal tumor showing adenocarcinoma.
CRIGM2017-9343896.002.jpg
PMC5469985_01_CRIGM2017-9343896.002.jpg
fig2
The biopsy showed adenocarcinoma of the esophagus (Figure 2).
H&E stain from liver biopsy with morphologically similar cells to the esophagus biopsy.
CRIGM2017-9343896.003.jpg
PMC5469985_01_CRIGM2017-9343896.003.jpg
fig3
The liver lesions were biopsied and the cells were morphologically similar to the cells from the esophageal tumor (Figure 3).
H&E stain of the bladder tumor with morphologically similar cells to the esophagus biopsy.
CRIGM2017-9343896.004.jpg
PMC5469985_01_CRIGM2017-9343896.004.jpg
fig4
Pathology was compared to the previous biopsy of the liver and was thought to be morphologically similar (Figure 4).
Bladder tumor with CK20 positive stain.
CRIGM2017-9343896.005.jpg
PMC5469985_01_CRIGM2017-9343896.005.jpg
fig5
Bladder tumor with positive stain for CDX2.
CRIGM2017-9343896.006.jpg
PMC5469985_01_CRIGM2017-9343896.006.jpg
fig6
Type Homeobox 2 (CDX2) positive (Figure 6), GATA3 negative in neoplastic cells (Figure 7), and Uroplakin negative in neoplastic cells (Figure 8).
Bladder tumor with negative stain for GATA 3 in neoplastic cells.
CRIGM2017-9343896.007.jpg
PMC5469985_01_CRIGM2017-9343896.007.jpg
fig7
Type Homeobox 2 (CDX2) positive (Figure 6), GATA3 negative in neoplastic cells (Figure 7), and Uroplakin negative in neoplastic cells (Figure 8).
Bladder tumor with negative stain for Uroplakin in neoplastic cells.
CRIGM2017-9343896.008.jpg
PMC5469985_01_CRIGM2017-9343896.008.jpg
fig8
Type Homeobox 2 (CDX2) positive (Figure 6), GATA3 negative in neoplastic cells (Figure 7), and Uroplakin negative in neoplastic cells (Figure 8).